Center for Clinical Trials of Sacramento

Sacramento, California 95823

0 studies enrolling now · 6 studies all time

What they study most

Asthma, Episodic Migraine, Gout, Migraine, Non-Eosinophilic Asthma, Type 2 Diabetes Mellitus

Studies at this site

• Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout — Completed
• Extension Study of ABP-671 in Participants With Gout — Stopped early
• A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. — Completed
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
• Albuterol HFA MDI in Pediatric Participants With Asthma — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed